Can your company help us commercialize products in our portfolio targeted at high income countries? We are looking for partnerships with companies that have established commercialization capacity at scale.
There are a number of products in the portfolio of our subsidiary, Global Access Diagnostics, that have significant revenue potential and we are actively looking for partners to help commercialize these.
The current products include our test for chronic obstructive pulmonary disease (COPD) and sepsis.
Contact us for more information
Our second area of partnership is product launch in lower and middle income countries (LMICs).
The high cost to sell and deploy products in many of the underserved markets in GAH’s target geographies makes it difficult for most private sector players to participate. Companies have to navigate a host of complex issues, from in-country regulatory requirements to a decentralized procurement approach.
Global Access Health has two related goals that can help you achieve impact with you product:
Market access capability for diagnostic product launches for a prioritized set of underserved markets in the Global South.
A channel access business line, collaborating with commercial partners who have products relevant to meet unmet needs of these underserved markets but lack capability in accessing the public markets and mobilization of donor / public funding.
GAH, through our portfolio company Global Access Diagnostics, has an extensive distribution network, relationships with national and regional institutions such as Ministries of Health, economic development blocs and global donors.
Get in touch to find out more about how we can work together to help get your product to people who need it most.
All Rights Reserved | Global Access Health